AMICAS is engaged in radiology and medical image and information management solutions. The AMICAS ONE Suite aims to provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully-integrated, HIS/RIS-independent PACS, featuring advanced enterprise workflow support and scalable design.
Latest Amicas News
Sep 27, 2019
Amicas, a provider of radiology and medical image and information management solutions, has completed its acquisition of Emageon—which settled a shareholder class action lawsuit in order to finalize the merger. In February, Amicas reported that one of its subsidiaries had commenced a tender offer to acquire all the outstanding shares of Emageon's common stock for approximately $39 million. As a result of the statutory merger completed Wednesday, Amicas now owns 100 percent of Birmingham, Ala.-based Emageon. Amicas had previously purchased 88 percent of Emageon common stock pursuant to the tender offer, which expired on April 1. Pursuant to the merger, Emageon shareholders who did not tender their shares (other than those shareholders who properly exercise their dissenters' rights), will receive the same $1.82 per share in cash, without interest and less any required withholding taxes, that was paid to shareholders in the tender offer. On March 27, Emageon said that it and the other named defendants in a putative class action lawsuit filed by its shareholders on March 13, in connection with the proposed acquisition of Emageon by Amicas, have entered into a memorandum of understanding with counsel for the plaintiff. Under the terms of the memorandum, the parties have agreed to settle the lawsuit, subject to court approval, at which time the lawsuit will be dismissed with prejudice. Emageon and the other defendants maintain that the lawsuit is "completely without merit." Nevertheless, to avoid costly litigation and eliminate the risk of any delay to the closing of the tender offer and subsequent merger, the defendants have agreed to the settlement contemplated in the memorandum, according to Emageon. The Boston-based Amicas said that the combined solution suite will include radiology PACS, cardiology PACS, RIS, cardiology information systems, revenue cycle management systems, referring physician tools, business intelligence tools and EMR-enabling enterprise content management capabilities. With the completion of the merger, Emageon has become a wholly owned subsidiary of Amicas, and Emageon shares will cease to be traded on the Nasdaq Global Market. Subscribe to Health Imaging News The free newsletter covering the top medical imaging headlines Email
Amicas Frequently Asked Questions (FAQ)
When was Amicas founded?
Amicas was founded in 1995.
Where is Amicas's headquarters?
Amicas's headquarters is located at 1210 Washington Street, Newton.
What is Amicas's latest funding round?
Amicas's latest funding round is Acq - P2P.
How much did Amicas raise?
Amicas raised a total of $30.67M.
Who are the investors of Amicas?
Investors of Amicas include Merge Healthcare, VitalWorks, Portage Venture Partners, Dell EMC, Beringea and 6 more.
Who are Amicas's competitors?
Competitors of Amicas include Abaxis, Applied Spectral Imaging, Fenwal, Micronics Microfluidics, Inoveon and 7 more.
Compare Amicas to Competitors
Atonomics develops a point of care diagnostic device based on an electro-mechanical concept. This technology changes the way that DNA and antibodies are used in point of care diagnosis.
Tensys Medical Tensys has developed a continuous, non-invasive blood pressure monitoring technology for cardiac output assessment that is easy to administer and comfortable for the patient. San Diego, CA.
Forth Photonics is a medical device company that designs, develops, manufactures and markets imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. Forth Photonics aims to help medical practitioners to improve patient care by incorporating advanced biophotonics and optical molecular imaging technologies to assist in early detection, diagnosis and monitoring.
Nanocrystal Imaging Corporation (NIC) was founded in October 1997 to exploit some of NCT's discoveries in the creation of high quality digital x-ray images. This has been a major objective of the medical imaging industry during the last decade. Digital x-ray imaging systems developed to date by other manufacturers do not produce images with sufficiently high resolution and contrast. After a 4-year effort, NIC has developed patented products and processes which can provide a reliable platform to achieve high quality digital x-ray imaging. The first of NIC's products for commercial use is addressed to the dental imaging market, and will be marketed by mid 2003. Products addressing other market will be available in successive years. in the creation of nano-sized luminescent particles with light output equivalent to that of commercial phosphors 1000 times larger
a privately held, early stage medical device company focused on the development of imaging technology for biomedical use. The company is currently in stealth-mode and not disclosing the finer details of its technology until it secures necessary intellectual property rights. Spectral Image will initiate a pilot study of its technology at a premier medical facilities in 2008.
Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.